Update on Tyrosine Kinase Inhibitors (TKI) in Metastatic Renal Cell Carcinoma - Cancer Network PDF Print
Cancer Network
A retrospective study of metastatic renal cell carcinoma (mRCC) patients published in the journal Cancer found that patients treated with tyrosine kinase inhibitors (TKIs) had better overall survival and

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.